Our results support the hypothesis that ADAM17 plays a key role in the shedding of soluble CX3CL1 in HP and CTD-ILD; however, in IPF probably another mechanism acts in CX3CL1 shedding. This evidence concerns the gene CX3CL1 and interstitial lung disease.